Necrotizing soft tissue infections after injection therapy: Higher mortality and worse outcome compared to other entry mechanisms

J Infect. 2015 Sep;71(3):312-6. doi: 10.1016/j.jinf.2015.05.013. Epub 2015 Jun 3.

Abstract

Objectives: Necrotizing Soft Tissue Infections represent a rare entity of infection associated with a high mortality. The aim of this retrospective study was to analyze patients with an iatrogenic etiology of injection or infiltration to compare the outcome with other etiologies.

Methods: The study group consisted of 21 patients treated with a Necrotizing Fasciitis caused by injection or infiltration. Risk factors and outcome were compared to 134 patients with a Necrotizing Fasciitis caused by other entry mechanisms.

Results: Overall mortality in our study group was 14 of 21 (67%) with an amputation rate of 11 of 15 (73%) if an extremity was involved. The survival rate was significantly worse after injection or infiltration (p < 0.001) as was the amputation rate (p = 0.013), the percentage of patients requiring intensive care (100% vs. 83%, p = 0.038) and vasopressors (81% vs. 54%, p = 0.02). Injection or infiltration therapy proved to be the strongest prognostic factor (p = 0.003) besides the known risk factors obesity (0.007) and renal insufficiency (0.025).

Conclusions: Our results demonstrate that patients with a Necrotizing Soft Tissue Infection after injection or infiltration therapy have a significantly worse prognosis.

Keywords: Injection therapy; Necrotizing fasciitis; Necrotizing soft tissue infection.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Amputation, Surgical / statistics & numerical data
  • Fasciitis, Necrotizing / etiology*
  • Fasciitis, Necrotizing / microbiology
  • Fasciitis, Necrotizing / mortality*
  • Fasciitis, Necrotizing / therapy
  • Female
  • Humans
  • Injections / adverse effects*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Soft Tissue Infections / etiology*
  • Soft Tissue Infections / microbiology
  • Soft Tissue Infections / mortality*
  • Soft Tissue Infections / therapy
  • Survival Rate
  • Treatment Outcome